Literature DB >> 2167159

Mechanisms of thymic lymphomagenesis by the retrovirus SL3-3.

E F Hays1, G Bristol, S McDougall.   

Abstract

These studies report changes occurring in the thymus of AKR and NFS/N mice after infection with the lymphomagenic retrovirus SL3-3. In virus-infected AKR fetal thymus, the programmed cell death caused by treatment with antibody to CD3 was remarkably diminished. A method of establishing thymic stromal cultures from mice of 1 to 3 wk of age is described. Using this method, it was found that SL3-3 virus infection by neonatal inoculation allowed establishment of thymic stromal cultures from organs removed from AKR mice of 30 to 50 days of age and from lymphomas, whereas thymic stromal cultures could not be established from control mice after 30 days of age. Using NFS/N mice which have no endogenous virus, it was shown that infection of thymic stroma precedes infection of thymocytes and that thymocytes are permissive for infection with SL3-3 virus but not for the nononcogenic retrovirus, Akv, yet Akv virus replicates efficiently in thymic stroma. SL3-3 virus integrates randomly in each lymphoma induced by this virus. The lymphomas are clonal or oligoclonal. Pim-1 and c-myc genes commonly rearranged in other virus-induced thymic lymphoma showed rearrangement in only a few lymphomas. A theory is proposed, based on the work presented here and in recent studies, which states that SL3-3 virus infection of thymic stroma allows infection of thymocyte progenitors entering from the bone marrow. These cells are then altered so that their maturation is delayed and their intrathymic survival is prolonged. This permits virus integration and reintegration that results in the genetic changes which transform the cell.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167159

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus.

Authors:  Karen Rulli; Jack Lenz; Laura S Levy
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Mink cell focus-forming murine leukemia virus infection induces apoptosis of thymic lymphocytes.

Authors:  F K Yoshimura; T Wang; F Yu; H R Kim; J R Turner
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.

Authors:  Anne Ahlmann Nielsen; Annette Balle Sørensen; Jörg Schmidt; Finn Skou Pedersen
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.

Authors:  A H Lund; J Schmidt; A Luz; A B Sørensen; M Duch; F S Pedersen
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family.

Authors:  A B Sørensen; A H Lund; S Ethelberg; N G Copeland; N A Jenkins; F S Pedersen
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3.

Authors:  A B Sørensen; M Duch; H W Amtoft; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Thymic dendritic cells are primary targets for the oncogenic virus SL3-3.

Authors:  C H Uittenbogaart; W Law; P J Leenen; G Bristol; W van Ewijk; E F Hays
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.